GINO MARTINI

Managing Director, Precision Health Technologies Accelerator (PHTA)

Professor Luigi ‘Gino’ Martini joins PHTA Ltd – a wholly-owned subsidiary of the University that will operate the new facility – from the Royal Pharmaceutical Society (RPS) where he has held the role of Chief Scientist for more than three years. With extensive experience in oncology, rare and infectious diseases, and drug development, Gino also brings expertise in policy development and external advocacy to his new appointment in Birmingham.

Gino’s career began with Senior Scientist roles at Scherer Drug Delivery Systems and SmithKline Beecham, before joining GSK – initially as Drug Delivery and Strategic Technologies Manager – rising to Senior Directorships across a 10-year stint.

An experienced academic, Gino was formerly Professor of Pharmaceutical Innovation at King’s College London, as well as undertaking visiting professorships and PhD supervision alongside his industry roles. Prior to his appointment at the RPS, he held senior development and advisory positions with Shire Pharmaceuticals and Roche.

Professor Martini is a Pharmacist and received his PhD in Drug Delivery from the University of Manchester. Professor Martini obtained his MBA with Distinction from the University of Liverpool, specialising in SME business failures and success. Professor Martini was made visiting Professor at John Moores University of Liverpool in 2006 and designated a Fellow of the Royal Pharmaceutical Society in 2008.

Professor Martini was appointed a member of the REF2014 sub-panel for Pharmacy, Dentistry, Nursing and Allied Healthcare professionals in 2011. Professor Martini has 10 patents and over 35 papers published in the field of Drug Delivery, Formulation and Innovative technologies.